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Mushroom bacilliform virus (MBV) is often found in cultivated mushrooms (Agaricus bisporus) with La France disease. MBV has
a 4-kb ssRNA genome of positive-sense encoding four major open reading frames (ORFs). The arrangement of ORFs at the 59 end
of the genome and the deduced amino-acid sequences of two of the putative gene products (protease and RNA-dependent RNA
polymerase) show remarkable similarity to some plant viruses, particularly subgroup II luteoviruses. We show that this similarity
extends to the translation strategy at the 59 end of the genome, the presence of a genome-linked protein (VPg), and the location
of the VPg downstream of the protease motifs in the polypeptide encoded by ORF2. © 1998 Academic Press
INTRODUCTION
Mushroom bacilliform virus (MBV) is the sole member of
the family Barnaviridae (Romaine, 1995). The virion is a
19 3 50-nm bacilliform particle encapsidating a ssRNA
positive-sense monopartite genome of 4 kb (Tavantzis et al.,
1980, 1983). MBV is associated with La France disease
(LFd) in the cultivated mushroom, Agaricus bisporus, al-
though the role of the virus in causing the disease is
unclear (Hollings, 1962; Hollings et al., 1968; van Zaayen,
1979). A second virus with an icosahedral shape and a
genome of dsRNA, La France infectious virus (LIV), is
strongly implicated as the primary cause of the disease
(Goodin et al., 1992; van der Lende et al., 1994). MBV is not
detected in healthy mushrooms and yet is not detected in
all cases of LFd (van Zaayen, 1979; Romaine and
Schlagnhaufer, 1995).
The MBV genome has been sequenced and contains
four major ORFs (1–4), encoding polypeptides of Mr
20,000, 73,000, 47,000, and 22,000, respectively (Fig. 1)
(Revill et al., 1994). The organisation of the MBV ORFs
and their deduced amino-acid sequences shows some
similarity to plant viruses, particularly subgroup II luteo-
viruses and sobemoviruses (Revill et al., 1994; Revill,
1995; Ma¨kinen et al., 1995).
ORF1 of MBV begins with AUG at nt 61 and overlaps
ORF2, which commences with AUG at nt 68. ORF1 also
contains a second in-frame AUG codon at nt 100. It has
not been determined which of these codons is used to
initiate translation. This is of some interest, as the pre-
ferred consensus sequence (xA/GxxAUGG) for initiation
of translation (Lu¨tcke et al, 1987; Kozak, 1989; Matthews,
1991) is not present for the first AUG in ORF1 and is only
partially satisfied for the first ORF2 AUG and the second
AUG in ORF1. To elucidate the translation strategy at the
59 end of the genome, genomic-length cDNA of MBV was
assembled, then transcribed and translated in vitro.
We also investigated whether MBV RNA has a ge-
nome-linked protein (VPg) at its 59 terminus. Recently,
van der Wilk et al. (1997) identified a VPg for potato
leafroll virus (PLRV), a subgroup II luteovirus. The VPg
was located in the ORF1 polyprotein (analogous to MBV
ORF2), downstream of the serine protease motifs. This
genome arrangement (protease-VPg-polymerase) is un-
usual, as all single-stranded RNA viruses for which a
VPg has been identified have the arrangement VPg-
protease-polymerase (Koonin and Dolja, 1993; van der
Wilk et al., 1997). Using radiolabelling and Edman deg-
radation, we have identified the VPg for MBV and shown
that it is located in a similar position on the genome to




The iodination with [125I] of a sample containing puri-
fied viral RNA and associated protein, followed by RNase
treatment, electrophoresis, and autoradiography, re-
vealed two products of Mr 16,000 (a) and Mr 15,000 (b)
(Fig. 2, lane 1). Proteinase K treatment removed both
products (Fig. 2, lane 2), indicative of the presence of
polypeptide. Edman degradation of unlabeled protein
associated with purified RNA yielded an unambiguous
single sequence of SEETDRYART, suggesting that the
polypeptide(s) resolved as the two bands in Fig. 2 had a
common N terminus and represented forms of VPg. The
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multiple forms of VPg may have resulted from heteroge-
neity in the length of the VPg itself or the attachment of
residual ribonucleotides.
The N-terminal sequence SEETDRYART is identical
to the deduced amino-acid sequence encoded by nu-
cleotides 1334–1363 in MBV ORF2 (residues 464–473),
demonstrating that the VPg is encoded downstream of
the putative serine protease motifs in ORF2 (Fig. 1).
The N-terminal portion of the MBV VPg sequence
showed no similarity to the PLRV VPg sequence (van
der Wilk et al., 1997).
In vitro translation
Translation of the full-length MBV RNA produced two
major polypeptides of approximate Mr 21,000 and 72,000,
and numerous minor polypeptides ranging in size from
Mr 18,000 to 60,000 (estimated on gel mobility; Fig. 3A,
lane 1). Similar results were obtained using either rabbit
reticulocyte lysates or wheat germ extracts for the trans-
lation experiments. Removal of the first AUG only in
FIG. 1. The MBV genome arrangement showing the predicted coding
regions for the N-terminal VPg sequence, coat protein (Cp), and puta-
tive serine protease (Pro) and RNA-dependent RNA polymerase (RdRp)
domains. Boxes with solid lines indicate the ORFs, each commencing
with the first AUG. The positions of the first and second AUGs in ORF1
are designated a and b, respectively. ORF3 upstream of the first ORF3
AUG is indicated by dashed lines. The constructs (C1–4) containing
changes to the first two AUGs in ORF1 are listed at the bottom of the
figure. Putative E/T and Q/S serine protease cleavage sites located
downstream of the VPg N terminus, and the approximate Mr of products
derived from cleavage at these sites, are shown. The approximate
location of the putative serine protease catalytic triad upstream of the
VPg sequence is also marked (H D S).
FIG. 2. Analysis by gel electrophoresis of the iodinated MBV VPg.
Samples were either treated with RNase A (RA, lane 1), or proteinase
K (PK, lane 2). The sizes of 14C-labeled molecular weight markers are
indicated (Mw).
FIG. 3. (A) Analysis by gel electrophoresis of in vitro translation
products following transcription of RNA from genomic-length MBV
cDNA clone pMBVFLC (C1), pMBV-2 (the second AUG codon in ORF1
altered to GCG, C2), pMBV-3 (the first AUG codon in ORF1 altered to
UAG, C3), or pMBV-4 (both AUGs altered, C4). The sizes of 14C-labeled
molecular weight markers are indicated (Mw). (B) Analysis by gel
electrophoresis and RIP of in vitro translation products precipitated by
antiserum directed against the polypeptide encoded by ORF1 [lanes
1–4, presented in the same order as (A) above], or ORF2 (lane 5, C1;
lane 6, C4). The sizes of the polypeptides (kDa) are indicated.
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ORF1 prevented synthesis of the Mr 21,000 polypeptide
(lane 3); however, removal of the second AUG in ORF1
(lane 2) had no detectable effect on translation. No
polypeptide of Mr 21,000 was detected when both AUGs
were removed (lane 4).
To identify the translation products encoded either by
ORF1 or ORF2, radioimmunoprecipitations (RIPs) were
performed using specific antibodies raised against bac-
terial fusion proteins containing either ORF1 or ORF2.
Polypeptide encoded by ORF1
Three lines of evidence indicated that the Mr 21,000
polypeptide produced following in vitro translation of
genomic-length RNA transcripts corresponded to the
polypeptide encoded by ORF1. First, antiserum raised
against the ORF1-encoded fusion protein immunopre-
cipitated the Mr 21,000 polypeptide (Fig. 3B, lanes 1 and
2). Second, the size of the ORF1 product (starting at nt 61)
calculated from the deduced amino acid sequence is Mr
20,000, close to the size determined by gel migration.
Third, removal of the first AUG at nt 61 in ORF1 prevented
the synthesis of the Mr 21,000 polypeptide (Figs. 3A,
lanes 3 and 4, and 3B, lanes 3 and 4).
A second polypeptide of Mr 19,000 was also immuno-
preciptated by the anti-ORF1 antiserum (Fig. 3B, lanes
1–4). Initiation at the second AUG in ORF1 at nt 100
would produce a protein of Mr 18,500. However, removal
of this AUG, either alone (Fig. 3B, lane 2), or in combi-
nation with the first ORF1 AUG (Fig. 3B, lane 4), did not
prevent production of the Mr 19,000 polypeptide. This
suggested that the Mr 19,000 polypeptide was not pro-
duced by translation from the second AUG but was an
unrelated polypeptide that was also immunoprecipitated
by the ORF1 antiserum. Thus the origin of the Mr 19,000
polypeptide remained unexplained.
Polypeptide encoded by ORF2
The size of the Mr 72,000 translation product (Fig. 3A,
lanes 1–4) estimated by gel migration was consistent
with that predicted for the polypeptide encoded by ORF2
(Mr 73,000). The product was also immunoprecipitated
by antiserum directed against the amino terminal portion
of the ORF2 protein, as were two additional polypeptides
of Mr 48,000 and Mr 50,000 (Fig. 3B, lanes 5 and 6). These
polypeptides may be either ORF2-related proteins or
nonspecific precipitates, since faint bands correspond-
ing to polypeptides of these sizes were also seen after
RIP with ORF1 antisera (Fig. 3B, lanes 1–4). Removal of
both flanking ORF1 AUGs had no apparent effect on
translation of the ORF2 product (Figs. 3A, lane 4, and 3B,
lane 6).
The detection of the lower-molecular-weight proteins
and the location of VPg within the ORF2 protein sug-
gested that the ORF2 protein is cleaved. A candidate for
the active protease is the ORF2 protein itself, since it
contains chymotrypsin-like serine protease motifs iden-
tified by Koonin and Dolja (1993) and shows some sim-
ilarity to the putative proteases of southern bean mosaic
virus (SBMV), pea enation mosaic virus (PEMV), and the
subgroup II luteoviruses PLRV and beet western yellows
virus (BWYV) (Fig. 4). However, replacement of the puta-
tive catalytic serine residue (and an adjacent conserved
glycine residue) with alanine using site directed mu-
tagenesis had no detectable effect on the products of in
vitro translation immunoprecipitated by the ORF2 anti-
serum (data not shown).
DISCUSSION
It has previously been shown that the 59 genome
arrangement of MBV is similar to some plant viruses,
particularly subgroup II luteoviruses, PEMV, and the cow-
pea strain of SBMV (Revill et al., 1994; Ma¨kinen et al.,
FIG. 4. Alignment of the chymotrypsin related serine protease motifs encoded by MBV ORF2 with those of a number of plant viruses, as defined
by Koonin and Dolja (1993). The amino acids of the putative catalytic triad identified by Gorbalenya et al. (1989) are highlighted in bold type. The
nucleotide number in the genomic sequence of the first base encoding the start of motif (i) is shown (a). The number of amino-acid residues from
the start of the ORF is shown (b), as is the number of residues between motifs (c). The identical amino acids are indicated by an asterisk. SBMV,
southern bean mosaic virus; PLRV, potato leafroll virus; BWYV, beet western yellows virus; PEMV, pea enation mosaic virus; MBV, mushroom
bacilliform virus.
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1995; Revill, 1995). In addition, the amino-acid sequences
for the putative serine protease and RNA-dependent
RNA polymerase (RdRp) genes for these viruses are
similar to MBV (Revill et al., 1994; Ma¨kinen et al., 1995;
Revill, 1995). Our results confirm that the similarity to
plant viruses extends to the initiation of protein synthesis
in vitro at the 59 end of the MBV genome where transla-
tion of a second ORF is initiated downstream of the start
point for the first ORF and to the location of the coding
sequence for the VPg, which is the same as for the
subgroup II luteovirus PLRV.
Translation of MBV ORF1 and ORF2 commences at the
first AUG in each reading frame, even though the preferred
Kozak sequence for initiation of translation (xA/GxxAUGG;
Lu¨tcke et al., 1987; Kozak, 1989; Matthews, 1991) is not
present for ORF1 (xUxxAUGA) and is only partially satisfied
for ORF2 (xAxxAUGU). This arrangement may facilitate ini-
tiation of translation at the second AUG (leaky scanning).
Other examples exist of plant viruses with overlapping
genes at the 59 end of genomic RNA, in which the fidelity of
the Kozak sequence is stronger for the second AUG than
the first. These include subgroup II luteoviruses (Mayo et
al., 1989; Veidt et al., 1992), PEMV (Demler and de Zoeten,
1991), and tymoviruses (Weiland and Dreher, 1989). In the
subgroup II luteoviruses PLRV and BWYV, products of the
expected size from both ORFs were also observed after in
vitro translation of genomic RNA (Mayo et al., 1989; Veidt et
al., 1992).
Removing the initiating codon in ORF1 had no appar-
ent effect on the amount of ORF2 polypeptide produced
(Fig. 3A, lanes 3 and 4), consistent with the findings of
Weiland and Dreher (1989), who showed that mutating
the ORF1 AUG of turnip yellow mosaic tymovirus had no
effect on cell-free translation of ORF2. Thus for both
viruses, initiation of translation at the first AUG in vitro is
not a significant impediment to initiation at the second.
The observed MBV ORF1 product of Mr 21,000 and the
ORF2 product of Mr 72,000 corresponded closely to the
predicted Mr of polypeptides encoded by ORF1 and
ORF2 (Mr 20,000 and Mr 73,000; Revill et al., 1994). The
numerous minor polypeptides ranging in size from Mr
18,000 to 60,000 (Fig. 3A) were possibly due to either
premature termination of translation, or the use of trun-
cated RNA molecules as template, or posttranslational
proteolysis. We were unable to demonstrate any in vitro
protease activity that could be ascribed to the motifs for
the putative serine protease in the ORF2 protein. Mu-
tagenesis of the predicted catalytic serine residue did
not change the polypeptide pattern observed. It is un-
likely that the mutated residue was incorrectly chosen,
since the primary sequence G-X-S-G for MBV is common
in other proteases where serine is the active residue
(Dougherty and Semler, 1993); however, serine protease
activity has not been reported for subgroup II luteovi-
ruses and sobemoviruses—the viruses most similar to
MBV based on amino-acid comparisons. If the putative
virus-encoded protease was not active in vitro, then the
polypeptides of Mr 50,000 and 48,000 may have arisen
from one of the processes mentioned above, with any
proteolysis due to a host enzyme. However, during virus
replication in infected cells, excision of VPg from the
ORF2 protein apparently occurs, and the best candidate
for this is the putative ORF2 serine protease.
The MBV ORF2-encoded putative serine protease, and
those of sobemoviruses, subgroup II luteoviruses, and
PEMV, are similar to the 3CPro cysteine proteases of picor-
naviruses but are unusual for plant viral proteases in having
a nucleophilic serine residue instead of cysteine in the
catalytic triad, similar to cellular serine proteases (Gorbale-
nya et al., 1988, 1989; Dougherty and Semler, 1993; Koonin
and Dolja, 1993). An analysis of the known cleavage sites
used by these enzymes enables predictions to be made
about the residues at the termini of other polypeptides they
cleave, such as the VPg of MBV.
Picornaviral 3CPro proteases cleave primarily at E(Q)/
S(G) sites and less frequently at E/T sites (Gorbalenya et
al., 1988, 1989; Wellink and van Kammen, 1988). In MBV,
an E/S dipeptide is present at the VPg N terminus (nt
1334, Fig. 1). Cleavage at a downstream E/T dipeptide (nt
1757, Fig. 1) would result in an Mr 16,300 polypeptide,
which is similar in size to the two VPg-related species
detected in these experiments (Mr 15,000 and 16,000).
Alternatively, cleavage at one of two Q/S sites down-
stream of the E/T site (nts 1780 and 1792, Fig. 1) would
produce proteins of Mr 17,000 or Mr 17,500, respectively,
again similar in size to the observed polypeptides.
The location of the MBV VPg downstream of the puta-
tive protease motifs encoded by ORF2 is the same as for
the VPg of the subgroup II luteovirus PLRV (van der Wilk
et al., 1997). However, the VPgs share no sequence
similarity and are markedly different in size, with an Mr of
7,000 for the PLRV VPg (Mayo et al., 1982), compared to
Mr 15,000 to 16,000 for MBV. However, the MBV VPg is
similar in size to that reported for another subgroup II
luteovirus, barley yellow dwarf virus (BYDV, approximate
Mr 17,000) (Murphy et al., 1989), although the location of
the coding sequence for the BYDV VPg is yet to be
determined. The shared genome arrangement (protease-
VPg-polymerase) of MBV and PLRV is unusual, as all
single-stranded RNA viruses for which a VPg has been
identified have the arrangement VPg-protease-polymer-
ase (Koonin and Dolja, 1993; van der Wilk et al., 1997).
The similarity of the MBV and PLRV genome arrange-
ments suggests related expression strategies for the two
viruses. Luteoviruses have small genomes (approximate-
ly 6 kb) and use several means of gene expression that
have been demonstrated experimentally. These include
internal initiation/leaky scanning, posttranslational pro-
teolysis, subgenomic RNA, ribosomal frameshifting, and
stop codon readthrough (reviewed by Matthews, 1991;
Miller et al., 1995). The results presented in this paper
show that MBV (i) expresses both ORF1 and ORF2, at
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least in a cell-free translation system, most likely by
leaky scanning, and (ii) codes for a VPg which is prob-
ably released by internal proteolysis of the ORF2
polyprotein. Other mechanisms of gene expression have
not been demonstrated experimentally, although the sim-
ilarity of the MBV genome arrangement to that of sub-
group II luteoviruses suggests it is likely that the coat
protein (ORF4) is translated from a subgenomic RNA,
and the putative viral polymerase (ORF3) is synthesised
as a fusion protein with the ORF2 protein by a 21
translational frameshift (Revill et al., 1994). Further stud-
ies are now underway using fungal protoplasts to deter-
mine the MBV translation strategy in vivo and to eluci-
date whether MBV can replicate in the absence of other
viruses linked with La France disease.
MATERIALS AND METHODS
DNA manipulations were performed essentially as de-
scribed by Sambrook et al. (1989), except where other-
wise indicated. All plasmids were cloned into Esche-
richia coli strain DH5a. PCR was performed using a
Corbett Research FTS-320 Thermal Sequencer, with the
following conditions: (i) 2 cycles of 94°C for 1 min, 50°C
for 1 min, and 72°C for 2 min; (ii) 28 cycles of 94°C for
30 s, 50°C for 30 s, and 72°C for 1 min; and (iii) 1 cycle
of 94°C for 30 s, 50°C for 30 s, and 72°C for 5 min. DNA
was sequenced on both strands of all constructs using a
PRISM™ Dyedeoxy™ Terminator Cycle Sequencing kit
and an automated sequencer (Applied Biosystems). Nu-
cleotide numbering refers to the MBV genome (Acces-
sion No. U07551, Revill et al., 1994).
Analysis of VPg
Commercially grown A. bisporus sporophores display-
ing symptoms typical of LFd (obtained from the same
farm as that used for earlier experiments; Revill et al.,
1994) were used as the source of virus. MBV was purified
from sporophores using the method of Tavantzis et al.
(1980), and stored at 270°C. RNA was extracted from
frozen MBV particles with a Qiagen RNeasy kit according
to the manufacturer’s instructions. Protein attached to 5
mg RNA was iodinated using chloramine T and 100 mCi
[125I] (2000 Ci/mmol) (Greenwood et al., 1963). The 125I-
labeled protein and RNA were treated with either 200
mg/ml RNase A or 1 mg/ml proteinase K (in 10 mM
Tris-Cl, 500 mM EDTA, pH 7.5) at 37°C for 30 min. The
products of digestion were electrophoresed through a
preformed 16.5% Tris-Tricine polyacrylamide gel (Bio-
Rad), and VPg was detected by autoradiography.
The N-terminal amino acid sequence of unlabeled VPg
was obtained using Edman degradation; the starting
material was VPg linked to 200 mg MBV RNA obtained
from purified virions as described above, and samples
were prepared for analysis using the method of van der
Wilk et al. (1997).
Genomic-length cDNA
To construct genomic length MBV cDNA, the 59 and 39
termini of MBV were amplified from appropriate cDNA
clones by PCR and ligated to a 3.8-kb MBV cDNA frag-
ment (nts 9–3809) contained in plasmid pMBV19. The
steps were as follows.
The 59 end (114 nt) was amplified from a 59 cDNA clone
(Revill et al., 1994), using an upstream primer (59GAG-
GATATCTAATACGACTCACTATAGACAAAATAATTGAAG39)
containing an EcoRV site, a T7 RNA polymerase promoter
sequence (italics), an additional G nucleotide for efficient
initiation of transcription, and the first 15 nucleotides of
MBV sequence (bold type). The downstream primer was
complementary to the MBV sequence (nts 114–84, 59CA-
GACCATGAGACATAGCCTTACACTCGTCG39). The PCR
product was blunt ended and phosphorylated using the
procedure of Starr and Quaranta (1991) and cloned into
SmaI-digested pUC18 (Pharmacia). The insert was re-
moved by digestion with EcoRV and NruI (nt 82) and ligated
into pMBV19 to produce pMBV1959.
The 39 end of the MBV genome was amplified from
cloned cDNA (Revill et al., 1994) using an upstream
primer (nts 3378–3402, 59GAGTTGAGTTCACTGATGTCC-
AGGC39) and a 39 terminal primer incorporating sequen-
tial SacII and HindIII restriction sites, and the last 49
nucleotides of MBV sequence (bold type) (59CCGCGG-
AAGCTTACCCAGCCACTCCAAAAGAAATTTCTTTCTTT-
ATGGAGCGACCTTCGAC). The PCR product was cloned
into pUC18 as described above, sequenced, and the
region containing the MBV 39 terminus excised by MunI
(nt 3457) and SacII digestion. The fragment was cloned
into pMBV1959, and the complete genomic-length frag-
ment incorporating the T7 promoter sequence was ex-
cised by HindIII digestion and cloned into pUC18 to
generate plasmid pMBVFLC.
Site-specific mutagenesis
ORF1. Three constructs containing mutations in one
or both of the first two AUGs in MBV ORF1 were
produced (Fig. 1, constructs 2–4). DNA (nts 36–422)
was amplified by PCR using gene-specific oligonucle-
otides incorporating the desired nucleotide change(s)
and cloned into SmaI-digested pUC18. The DNA was
then digested with BglII (nt 40) and XhoI (nt 287), and
the fragment was cloned into plasmid pMBVFLC. Con-
struct 1 refers to the parental and unmutated genomic-
length cDNA (pMBVFLC). In construct 2, the second
AUG in ORF1 (nt 100) was altered to GCG, leaving the
first AUG (nt 61) intact (pMBV-2). For construct 3
(pMBV-3), the first AUG in ORF1 (nt 61) was altered to
UAG. For construct 4, pMBV-2 served as template
DNA, enabling both AUGs to be altered to UAG and
GCG, respectively (pMBV-4).
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ORF2 encoded protease
To determine whether the putative serine protease
encoded by MBV ORF2 was active in vitro, the putative
catalytic serine residue (Gorbalenya et al., 1988, 1989;
Dougherty and Semler, 1993; Revill, 1995) and adjacent
glycine (conserved in subgroup II luteoviruses and MBV,
Fig. 2.) were both altered to alanine using the overlap
PCR method (Ho et al., 1989). The DNA incorporating the
desired nucleotide changes was cloned into SmaI-di-
gested pUC18, then excised by digestion with StuI and
XhoI and ligated into plasmid pMBVFLC. Following clon-
ing into E. coli, the mutated plasmid was known as
pMBVPro.
Production of fusion proteins and antisera
DNA corresponding to nucleotides 60–600 of MBV
was amplified by PCR using cDNA as template, and
flanking primers designed to introduce BamHI and EcoRI
sites at the 59 and 39 ends, respectively. The PCR product
was cloned into the BamHI/EcoRI sites of pGEX3X (pro-
ducing pORF1–3X) and pGEX2T (producing pORF2–2T)
(Pharmacia). These plasmids have restriction sites in
different reading frames, such that expression of
pORF1–3X in E. coli produced a polypeptide comprised
of glutathione-S-transferase (GST) fused to the complete
ORF1 gene product, and expression of pORF2–2T pro-
duced a polypeptide corresponding to GST fused to the
145 amino terminal residues of ORF2. Following sonica-
tion and pelleting of the cell debris, the soluble fraction
was analysed by polyacryalmide gel electrophoresis
(PAGE), and polypeptides of the predicted size for MBV
ORF1 and ORF2 products fused to GST were excised
from the gel. Antisera to these polypeptides were raised
by injecting rabbits with macerated gel extracts and
bleeding at regular intervals, using standard protocols
(Harlow and Lane, 1988).
In vitro transcription and translation of genomic-
length constructs
Plasmid pMBVFLC (5 mg DNA) and mutant constructs
were linearised with SphI, leaving 8 nt of non-MBV se-
quence and a 39 overhang at the 39 end of the MBV
genomic-length cDNA. The DNA was blunt-ended with
the Klenow fragment of DNA polymerase, and RNA was
transcribed using T7 RNA polymerase (Ribomax™ kit,
Promega) in the presence of 1 mM of the cap analog
m7G(59)ppp(5)G according to the manufacturer’s instruc-
tions. The concentration and integrity of the RNA was
determined by electrophoresis through an agarose gel
containing formaldehyde and ethidium bromide staining.
Following phenol/chloroform extraction and ethanol pre-
cipitation, 1 mg of RNA was translated for 90 min in the
presence of 30 mCi of translation grade [35S]methionine
(1175 Ci/mmol, ICN Pharmaceuticals), using rabbit re-
ticulocyte lysates or wheat germ extracts (Promega).
Products were analysed by electrophoresis through 14%
polyacryalamide gels and autoradiography.
Radioimmunoprecipitation analysis
The translation mix (10 ml) was added to 100 ml lysis
buffer (Smith and Wright, 1985), containing 1 mg/ml Pe-
fabloc (Boehringer Mannheim). The lysate was pre-ab-
sorbed with 50 ml protein A Sepharose (Pharmacia) for
1 h at 4°C, cleared by microcentrifugation, and 4 ml of
antisera was added and mixed for 12–16 h at 4°C. The
immunoprecipitate was bound to 50 ml protein A Sepha-
rose for 1 h at 4°C, collected by microcentrifugation,
washed (Smith and Wright, 1985), and analysed by elec-
trophoresis through 14% polyacryalamide gels and sub-
sequent autoradiography.
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